United States Solid Tumors Drug Sales Market Report 2020

July 2016 | 106 pages | ID: U21BA55EF2BEN
QYResearch

Abstracts

This report studies sales (consumption) of Solid Tumors Drug in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• F. Hoffmann-La Roche
• Novartis
• Celgene
• Johnson & Johnson
• Pfizer
• BMS
• Bayer
• AbbVie
• Boston Biomedical
• Eli Lilly
• GSK
• Merck
• Novartis
• Sanofi

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Solid Tumors Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Solid Tumors Drug Sales Market Report 2021

1 SOLID TUMORS DRUG OVERVIEW

1.1 Product Overview and Scope of Solid Tumors Drug
1.2 Classification of Solid Tumors Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Solid Tumors Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size (Value and Volume) of Solid Tumors Drug (2011-2021)
  1.4.1 USA Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  1.4.2 USA Solid Tumors Drug Sales and Growth Rate (2011-2021)
  1.4.3 USA Solid Tumors Drug Revenue and Growth Rate (2011-2021)

2 USA SOLID TUMORS DRUG COMPETITION BY MANUFACTURERS

2.1 USA Solid Tumors Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Solid Tumors Drug Revenue and Share by Manufactures (2015 and 2016)

3 USA SOLID TUMORS DRUG (VOLUME AND VALUE) BY TYPE

3.1 USA Solid Tumors Drug Sales and Market Share by Type (2011-2021)
3.2 USA Solid Tumors Drug Revenue and Market Share by Type (2011-2021)

4 USA SOLID TUMORS DRUG (VOLUME) BY APPLICATION

5 USA SOLID TUMORS DRUG MANUFACTURERS ANALYSIS

5.1 F. Hoffmann-La Roche
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Solid Tumors Drug Product Type and Technology
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Solid Tumors Drug Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
5.2 Novartis
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Novartis (2015 and 2016)
5.3 Celgene
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Celgene Product Type and Technology
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Celgene Sales, Revenue, Price of Celgene (2015 and 2016)
5.4 Johnson & Johnson
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Boston Biomedical Product Type and Technology
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.5 Pfizer
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Pfizer Product Type and Technology
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.6 BMS
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 BMS Product Type and Technology
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 BMS Sales, Revenue, Price of BMS (2015 and 2016)
5.7 Bayer
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Bayer Product Type and Technology
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Bayer Sales, Revenue, Price of Bayer (2015 and 2016)
5.8 AbbVie
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 AbbVie Product Type and Technology
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 AbbVie Sales, Revenue, Price of AbbVie (2015 and 2016)
5.9 Boston Biomedical
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Boston Biomedical Product Type and Technology
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Boston Biomedical Sales, Revenue, Price of Boston Biomedical (2015 and 2016)
5.10 Eli Lilly
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Eli Lilly Product Type and Technology
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Eli Lilly Sales, Revenue, Price of Eli Lilly (2015 and 2016)
5.11 GSK
5.12 Merck
5.13 Novartis
5.14 Sanofi

6 SOLID TUMORS DRUG TECHNOLOGY AND DEVELOPMENT TREND

6.1 Solid Tumors Drug Technology Analysis
6.2 Solid Tumors Drug Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Solid Tumors Drug
Table Classification of Solid Tumors Drug
Figure USA Sales Market Share of Solid Tumors Drug by Type in 2015
Table Applications of Solid Tumors Drug
Figure USA Sales Market Share of Solid Tumors Drug by Application in 2015
Table USA Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure USA Solid Tumors Drug Sales and Growth Rate (2011-2021)
Figure USA Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Table USA Solid Tumors Drug Sales of Key Manufacturers (2015 and 2016)
Table USA Solid Tumors Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drug Sales Share by Manufacturers
Figure 2016 Solid Tumors Drug Sales Share by Manufacturers
Table USA Solid Tumors Drug Revenue by Manufacturers (2015 and 2016)
Table USA Solid Tumors Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Solid Tumors Drug Revenue Share by Manufacturers
Table 2016 USA Solid Tumors Drug Revenue Share by Manufacturers
Table USA Solid Tumors Drug Sales and Market Share by Type (2011-2021)
Table USA Solid Tumors Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Solid Tumors Drug by Type (2011-2021)
Figure USA Solid Tumors Drug Sales Growth Rate by Type (2011-2021)
Table USA Solid Tumors Drug Revenue and Market Share by Type (2011-2021)
Table USA Solid Tumors Drug Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Solid Tumors Drug by Type (2011-2021)
Figure USA Solid Tumors Drug Revenue Growth Rate by Type (2011-2021)
Table USA Solid Tumors Drug Sales and Market Share by Application (2011-2021)
Table USA Solid Tumors Drug Sales Share by Application (2011-2021)
Figure Sales Market Share of Solid Tumors Drug by Application (2011-2021)
Figure USA Solid Tumors Drug Sales Growth Rate by Application (2011-2021)
Table F. Hoffmann-La Roche Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Novartis Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Celgene Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Celgene (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table Pfizer Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
Table BMS Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of BMS (2015 and 2016)
Table Bayer Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Bayer (2015 and 2016)
Table AbbVie Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of AbbVie (2015 and 2016)
Table Boston Biomedical Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Boston Biomedical (2015 and 2016)
Table Eli Lilly Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table GSK Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of GSK (2015 and 2016)
Table Merck Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Merck (2015 and 2016)
Table Novartis Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Sanofi Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Sanofi (2015 and 2016)